Friday, May 25, 2018
Video: Page (1) of 1 - 09/07/13 Email this story to a friend. email article Print this page (Article printing at page facebook
Cancer Monitoring Technology In The Future?

By DMO Affiliate
This morning, Trovagene (TROV) announced it has entered into a clinical collaboration agreement with the University of Southern California study the effectiveness of the company's cell-free DNA assay. The goal is to show that Trovagene's technology is able to identify the cancer's genomic changes following treatment and to track the progression of the disease.
Cancer Monitoring Technology In The Future?

Page: 1


Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines